StopCoV - 30-50 year olds
The population is composed of individuals between the ages of 30 and 50 years old that will receive or have received a first or second dose of a COVID-19 vaccine at an Ontario vaccine distribution center.
The population is composed of individuals between the ages of 30 and 50 years old that will receive or have received a first or second dose of a COVID-19 vaccine at an Ontario vaccine distribution center.
-
Minimum age
-
30
-
Maximum age
-
50
-
Newborns
-
-
Twins
-
-
Countries
-
-
Territory
-
-
Ethnic Origin
-
-
Health Status
-
-
Other Criteria
-
Inclusion: Individuals who can speak, read and understand English (or have a trusted individual to help with study procedures).
Exclusion: - Individuals who are less than 30 years or those 51-69 years.
- Those who are unable to complete the study protocols in English either alone or with the assistance of a trusted individual with an electronic device.
- Participants who enroll but do not receive any dose of the vaccine.
-
Sources of recruitment
-
-
General Population
-
-
Supplementary Information
-
A random sample of emails of persons registering for vaccination at an Ontario center who provide their email and consent to be contacted for research in the target population age groups will be forwarded by the Ministry of Ontario to the study site. The study site in turn will forward the email blast electronically to the participants on the list directing them to the STOPCoV study website. Pamphlets and posters describing the study and providing the website and contact information will be made available at Toronto vaccine distribution centers, primary care offices, pharmacies and community organizations supporting vaccine uptake.
-
Number of Participants
-
400
-
Number of Participants with Biological Samples
-